Leukoreduction as a control measure in transfusion transmission of visceral leishmaniasis.

Loren Queli PereiraSarah Cristina Sato Vaz TanakaMárcia Maria Ferreira-SilvaFrancisca Vânia Barreto Aguiar Ferreira GomesMelissa Palis SantanaPaulo Roberto AguiarGilberto de Araújo PereiraCésar Gómez-HernándezVirmondes Rodrigues JuniorFernanda Bernadelli De VitoHelio Moraes-Souza

Published in: Transfusion (2023)

Higher prevalence in the group with HNL and low prevalence in those who received LH, similar to NT patients, highlight the risk of transfusional VL transmission and reinforce the role of leukoreduction in its prevention.

Keyphrases

end stage renal disease
risk factors
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
prognostic factors
cardiac surgery
acute kidney injury
patient reported outcomes
sickle cell disease